BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 17, 2017
View Archived Issues
Fortress Biotech launches subsidiary Cyprium Therapeutics
Read More
National Institutes of Health awards SBIR phase II grant to TherapyXinc
Read More
Bellicum initiates phase I study of BPX-701 in relapsed or refractory myeloid neoplasms
Read More
Acceleron plans phase II trial of ACE-83 in Charcot-Marie-Tooth disease
Read More
Medicenna collaborates with MD Anderson on fusion protein therapeutics targeting IL4R
Read More
Aerpio Pharmaceuticals completes reverse merger
Read More
25-hydroxycholesterol protects against ZIKV-induced microcephaly in vivo
Read More
Tempus and University of Chicago establish collaboration in breast cancer
Read More
Bumetanide improves symptoms of autism; Servier and Neurochlore to collaborate on treatment
Read More
PTC Therapeutics to acquire Emflaza for the treatment of Duchenne muscular dystrophy in U.S.
Read More
Theralase demonstrates 18-month stability of its next-generation anticancer PDC, TLD-1433
Read More
Momotaro-Gene raises funding to support development of Ad-SGE-REIC
Read More
Clinigen partners with Diurnal to launch European managed access program for Infacort and Chronocort
Read More
Provecs, Medac and Cevec establish adenoviral vector collaboration in oncology
Read More
FDA issues complete response letter for ZS-9 for hyperkalemia
Read More
23-gene signature distinguishes malignant melanoma from benign nevi
Read More
New trial to combine Reolysin with Imnovid or Revlimid in patients with relapsing myeloma
Read More
Bioequivalence demonstrated for gemigliptin/rosuvastatin FDC and individual drugs
Read More
BIO-FLARE collaboration explores biological factors that trigger flares in rheumatoid arthritis
Read More
Chinese funding supports PegBio's development of GLP-1 analogue PB-119
Read More
Bristol-Myers Squibb patents activin receptor-like kinase 5 inhibitors
Read More
Arbutus licenses LNP technology to Alexion for use in rare disease program
Read More
Auckland Uniservices discloses new IDO and/or TDO inhibitors
Read More
Circassia reaches agreement with AstraZeneca on U.S. commercial rights for Tudorza and Duaklir
Read More
Incyte Corp discovers TAM kinases inhibitors
Read More
Taiho Pharmaceutical presents HER2 inhibitors
Read More
Actelion Pharmaceuticals discovers antibacterial annulated pyrrolidin-2-one derivatives
Read More
Jiangsu Hansoh Pharmaceutical Group, Shanghai Hansoh Biomedical present angiotensin AT2 antagonists
Read More
Bellus Health to sell Thallion Pharmaceuticals subsidiary to Taro
Read More
Genentech and Xenon Pharmaceuticals develop Nav1.7 channel blockers
Read More
Sunshine Lake Pharma identifies urate transporter 1/xanthine oxidase inhibitors
Read More